Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0034 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-095 |
filingDate |
2013-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2015-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20150034796-A |
titleOfInvention |
Misoprostol formulation |
abstract |
The present invention relates to a method for reducing the likelihood of the development of an infection in which the use of antibiotics is necessary after induction of labor or induction of labor in a woman, said method comprising the step of applying an insert comprising a crosslinked polyurethane reaction product of polyethylene glycol, triol and diisocyanate, Wherein the insert contains 200 micrograms of microprost, wherein the likelihood of infection is reduced as compared to administration of an insert containing 10 mg of dynprostonose . |
priorityDate |
2012-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |